- info@slni.org
- Maitama, FCT 904101, Abuja.
Relatives pour into the compound from Nasarawa and Adamawa. A stewpot scandal escalates fast. It’s Aunty Jemilla, calm and commanding, who defuses the shouting with one sharp look. The wedding week has only just begun, and already, the house is shaking.
‘Yan uwa sun yi ta kwarara cikin harabar daga Nasarawa da Adamawa. Wani abin kunya na stewpot yana karuwa da sauri. Aunty Jemilla ce mai natsuwa da ba da umarni, ta kawar da ihun da kaifi daya. An fara satin daurin aure, kuma tuni gidan na rawa.
HPV (Human Papillomavirus) is a very common virus that can infect both men and women. There are many types of HPV, but some can lead to serious health problems, including cervical cancer in women, as well as other cancers and genital warts in both men and women.
Most HPV infections go away on their own without causing any problems, but certain high-risk types can lead to cancer over time. The HPV vaccine protects against the most dangerous types of the virus. In Nigeria, the National Primary Health Care Development Agency (NPHCDA) has approved the HPV vaccine for girls starting at age 9.
HPV is a virus that spreads through skin-to-skin contact, and the HPV vaccine helps prevent it from causing cancer later in life.
The HPV vaccine prevents cervical cancer and is safe and effective. The WHO recommends that women ages 9 – 45 receive the HPV Vaccine. The vaccine is most effective if administered to girls when they are young, before exposure to HPV, thus, the primary participant audience for vaccination are girls aged 9 to 14 years old.
Yes, HPV vaccines are available for girls aged 9 to 14 years old. Find a Primary Healthcare Center closest to you and get the vaccine for free
You can receive the HPV vaccine in any Primary Healthcare Center closest to you. Find a vaccine here: LINK
The HPV vaccine prevents the HPV strains that cause approximately 70% of cervical cancer. Cervical cancer is one of the most common cancers affecting women, causing 266,000 annual deaths worldwide. In Nigeria, cervical cancer is the second most common cancer among women. Women who get cervical cancer often cannot get pregnant again because the disease affects their wombs and treatments often involve surgical removal of the womb.
The HPV vaccine prevents the HPV strains that cause approximately 70% of cervical cancer. Cervical cancer is the cancer of the lower part of the uterus (womb), therefore it’s a disease seen only in women.
The vaccine is manufactured in accordance with religious law (for example, it has been certified as halal).
Eighty-six countries, including Nigeria, have introduced HPV vaccine into their national immunization schedules.
The HPV vaccine does not harm girls’ fertility. In fact, HPV and other sexually transmitted infections that are known to affect fertility may be prevented through HPV vaccination, thereby providing a beneficial effect on fertility in addition to preventing cervical cancer.
Yes. WHO Advisory Committee for Vaccine Safety has closely monitored the safety of HPV vaccines, reviewing data and studies from all over the world. A WHO 2017 review of over 270 million doses of HPV vaccine concluded the vaccine has an excellent safety profile and no major adverse events.
No. Studies confirm that receiving the HPV vaccine does not influence sexual behavior. The focus of the vaccine is on preventing Cervical cancer and other related diseases, not encouraging sexual activity .
Encourage discussions about the importance of the HPV vaccine among parents, schools, and healthcare providers. Support public health campaigns aimed at promoting vaccinations for both boys and girls
No, the HPV vaccination does not aim to control the population of Nigerians. Its primary purpose is to protect young girls from cancers caused by the Human Papillomavirus (HPV) such as cervical cancer. The vaccine has been extensively tested and is recommended by health organizations like the World Health Organization (WHO) and the Nigerian Ministry of Health as a preventive measure against cervical cancer.
The HPV vaccine is generally safe, with mild side effects such as pain at the injection site, fever, and dizziness, while serious side effects like allergic reactions are extremely rare.
Parents can get information from healthcare providers, the Nigerian Ministry of Health, WHO publications, public health campaigns, and reputable online sources.
No, the HPV vaccine does not contain any microchips or tracking devices. This myth is baseless and has been thoroughly debunked by health experts and organizations.
No, the HPV vaccine is not associated with any Illuminati signs. Such myths are entirely false. The vaccine’s purpose is to protect against HPV-related diseases and is supported by credible health organizations globally.
For girls aged 9 to 14 years, the standard recommendation is two doses of the HPV vaccine, spaced 6-12 months apart.
The HPV vaccine provides long-lasting protection against the human papillomavirus. Studies have shown that the vaccine can last for at least 10 years, with evidence pointing to even longer protection without a need for booster shots.
Common signs of cervical cancer are unusual pelvic pain or bleeding. If you are concerned about any symptoms you are a loved one are having, please reach out to a doctor or visit a PHC near you.
Most cervical cancers are caused by the human papillomavirus, also called HPV. Cervical cancer begins when healthy cells in the cervix develop changes in their DNA. The HPV vaccine prevents the HPV strains that cause approximately 70% of cervical cancer.
The HPV vaccine prevents the HPV strains that cause approximately 70% of cervical cancer. Cervical cancer is the cancer of the lower part of the uterus (womb), therefore it’s a disease seen only in women.
The vaccine is most effective if administered to girls when they are young, before exposure to HPV, thus, the primary participant audience for vaccination are girls aged 9 to 14 years old.
The HPV vaccine prevents the HPV strains that cause approximately 70% of cervical cancer. Cervical cancer is one of the most common cancers affecting women, causing 266,000 annual deaths worldwide. In Nigeria, cervical cancer is the second most common cancer among women. Women who get cervical cancer often cannot get pregnant again because the disease affects their wombs and treatments often involve surgical removal of the womb.
Generally, the HPV vaccine is for males and females up to 45 years old. But in Nigeria, the vaccine at primary health centers is mainly for girls aged 9-14 years. This could change later to include other age groups in Nigeria. However, if you are older or not sure if you qualify, you can ask a doctor at a private hospital about getting the vaccine.
Breastfeeding mothers can safely get the HPV vaccine. It does not harm the baby or make the vaccine work less. It is perfectly fine to keep breastfeeding after getting vaccinated.
If you suspect you have an HPV infection, it is important to visit a hospital and consult a doctor. The doctor will discuss your symptoms, recommend necessary tests, and provide the most suitable treatment based on the results.
The HPV vaccine is not recommended for pregnant women. However, it is safe for breastfeeding women.
Yes, someone with high blood pressure can take the HPV vaccine. However, it is important that their blood pressure is under control. They should see their doctor and ensure that they are on the appropriate medications before taking the vaccine.
Yes, someone who had a mastectomy can safely take the HPV vaccine, as it protects against cancers caused by the human papillomavirus and does not depend on breast health. Unless there are specific health concerns, the vaccine is generally safe and recommended. If in doubt, please consult with your doctor.
Currently, the National Primary Health Care Development Agency (NPHCDA) recommends that the HPV vaccine be given free to girls ages 9-14 in primary health centers. However, those above this age group, should go to private hospitals for inquiries.
Your daughter can receive the HPV vaccine once she turns 9 years old. This means she can get the vaccine anytime between March 2025 and February 2026. Wishing her a happy birthday in advance. 🎂 🎉 🎁
HPV (Human Papillomavirus) wata kwayar cuta ce da take yawan yaduwa sosai wadda ke iya shafar maza da mata. Akwai nau’uka daban-daban na HPV, amma wasu daga cikinsu na iya haifar da matsalolin lafiya masu tsanani, ciki har da cutar sankarar mahaifa a mata, da sauran nau’ukan sankara da ciwon fuka a al’aura ga maza da mata.
Yawancin kamuwa da HPV na wucewa da kansu ba tare da haifar da wata matsala ba, amma wasu nau’uka masu haɗari na iya haddasa cutar sankara a tsawon lokaci. Allurar rigakafin HPV tana kare mutum daga mafi hatsarin nau’ukan wannan kwayar cuta. A Najeriya, Hukumar Raya Lafiyar Firamare ta Kasa (NPHCDA) ta amince da allurar rigakafin HPV ga ‘yan mata tun daga shekara 9.
HPV kwayar cuta ce da ke yaduwa ta hanyar hulɗar fata da fata, kuma allurar rigakafin HPV tana taimakawa wajen hana ta haddasa cutar sankara a gaba.
Allurar rigakafin HPV na hana kansar mahaifa kuma ba ta da illa ga kuma tasiri. WHO ta ba da shawarar cewa mata masu shekaru 9-45 su sami allurar HPV. Allurar rigakafi ta fi tasiri idan aka yi wa ƴaƴa mata tun suna kanana, kafin kamuwa da cutar ta HPV, don haka, farkon masu sauraron rigakafin su ne ƴaƴa mata masu shekaru 9 zuwa 14.
Eah, ana samun allurar rigakafin HPV ga ƴaƴa mata masu shekaru 9 zuwa 14. Nemo Cibiyar Kiwon Lafiya ta Farko mafi kusa da ku kuma za’a sami allurar rigakafin kyauta
Kuna iya karɓar allurar rigakafin HPV a kowace Cibiyar Kiwon Lafiya ta Farko mafi kusa da ku.Nemo allurar rigakafi anan: MAHADI
Allurar rigakafin HPV na hana wata irin nau’in HPV wanda ke haifar da kusan kashi 70% na kansar mahaifa. Ciwon kansar na mahaifa yana daya daga cikin cututtukan kansa da ke shafar mata, wanda ke haifar da mutuwar mutane 266,000 a duk duniya. A Najeriya, cutar kansar mahaifa ita ce ta biyu mafi yawan cutar kansa a tsakanin mata. Matan da ke fama da cutar kansar mahaifa sau da yawa ba za su iya sake yin ciki ba saboda cutar tana shafar mahaifar su kuma sau da yawa jinyar ta haɗa da cire mahaifar ta hanyan tiyata.
Allurar rigakafin HPV na hana wata irin nau’in HPV wanda ke haifar da kusan kashi 70% na kansar mahaifa. Ciwon kansa na mahaifa shine ciwon kansa na ɓangaren ƙasa da mahaifa (mahaifa), saboda haka cuta ce da ake gani a cikin mata kawai.ent
Ana sarrafa allurar rigakafin kamar yadda dokar addini ta tanadar (misali, an tabbatar da ita a matsayin halal).
Kasashe tamanin da shida, ciki har da Najeriya, sun gabatar da allurar rigakafin cutar ta HPV a cikin jadawalin rigakafin su na kasa.
Allurar rigakafin HPV ba ta cutar da yaya mata ta bangaren samun haihuwa. A haƙiƙa, HPV da sauran cututtukan da ake ɗauka ta hanyar jima’i waɗanda aka san suna shafar haihuwa ana iya hana su ta hanyar rigakafin HPV, don haka tana samar da tasiri mai amfani akan haihuwa baya ga hana ciwon kansar na mahaifa.
Eah. Kwamitin ba da shawara na WHO don Kariyar Allurar rigakafi ya sa ido sosai kan amincin allurar HPV, yin bitar bayanai da nazari daga ko’ina cikin duniya. Binciken WHO na 2017 na fiye da allurai miliyan 270 na rigakafin HPV sun kammala da cewa allurar yana da kyakkyawan bayanin martabar aminci kuma babu manyan abubuwan da ba su da kyau.
A’a. Bincike ya tabbatar da cewa karbar allurar rigakafin cutar ta HPV baya tasiri ga halayen jima’i. Abin da allurar ke mayar da hankali akai shine rigakafin cutar kansar mahaifa da sauran cututtuka masu alaƙa, ba ƙarfafa ayyukan jima’i ba.
Ƙarfafa tattaunawa game da mahimmancin rigakafin HPV tsakanin iyaye, makarantu, da ma’aikatan kiwon lafiya. Tallafa kamfen na kiwon lafiyar jama’a da nufin inganta rigakafin yara maza da mata
A’a, rigakafin HPV ba ya nufin sarrafa yawan al’ummar Najeriya. Babban manufarsa ita ce kare ƴaƴa mata daga cututtukan kansa da ƙwayar cuta ta (HPV) ke haifarwa kamar kansar mahaifa. An yi gwajin allurar sosai kuma kungiyoyin lafiya kamar Hukumar Lafiya ta Duniya (WHO) da ma’aikatar lafiya ta Najeriya suka ba da shawarar a matsayin matakin kariya daga cutar kansar mahaifa.
Allurar rigakafi ta HPV gabaɗaya tana da lafiya, tare da ƙananan illolin kamar zafi a wurin allura, zazzabi, da jiri, yayin da munanan illolin kamar halayen rashin lafiyan ba su da yawa.
Iyaye za su iya samun bayanai daga ma’aikatan kiwon lafiya, Ma’aikatar Lafiya ta Najeriya, wallafe-wallafen WHO, fafutukar kiwon lafiyar jama’a, da kuma sanannun hanyoyin yanar gizo.
A’a, allurar rigakafi na HPV bai ƙunshi kowane na’ura ko na’urorin sa ido ba. Wannan tatsuniya ba ta da tushe kuma masana kiwon lafiya da kungiyoyi sun yi watsi da ita sosai.
A’a, allurar rigakafin ta HPV ba ta da allaka da kowane alamun kungiyar asiri. Irin wadannan tatsuniyoyi gaba daya karya ne. Manufar rigakafin ita ce kariya daga cututtukan da ke da alaƙa da HPV kuma ana samun tallafi daga sahihan ƙungiyoyin kiwon lafiya a duniya.
Ga ƴaƴa mata masu shekaru 9 zuwa 14, daidaitattun shawarwarin shine allurai biyu na rigakafin HPV, wanda aka raba tsakanin watanni 6-12.
Allurar rigakafin HPV tana ba da kariya mai dorewa daga cutar kansar mahaifa. Bincike ya nuna cewa maganin na iya dawwama aƙalla shekaru 10, tare da shaidar da ke nuna ƙaruwan ƙariya ba tare da buƙatar ɗaukar wata allurar ba.
Alamun gama gari na ciwon kansar mahaifa sune ciwon mara ko zubar jini da ba a saba gani ba. Idan kun damu da kowace irin alamun da kuke da ita ko waƴan da kuke ƙauna, da fatan za ku tuntuɓi likita ko ku ziyarci PHC kusa da ku.
Yawancin ciwon kansar na mahaifa suna samuwa ne ta ƙwayar cuta wanda ke da alaka da
jima’i, wanda ake kira HPV. Ciwon kansar na mahaifa yana farawa lokacin da lafiyayyun kwayoyin halitta a cikin mahaifa suka samu canje-canje a cikin DNA ɗin su. Allurar rigakafin HPV tana hana nau’ukan HPV waɗanda ke haifar da kusan kashi 70% na kansar mahaifa.
Allurar rigakafin HPV na hana wata irin nau’in HPV wanda ke haifar da kusan kashi 70% na kansar mahaifa. Ciwon kansa na mahaifa shine ciwon kansa na ɓangaren ƙasa da mahaifa (mahaifa), saboda haka cuta ce da ake gani a cikin mata kawai.
Allurar rigakafi ta fi tasiri idan aka yi wa ƴaƴa mata tun suna kanana, kafin kamuwa da cutar ta HPV, don haka, farkon masu sauraron rigakafin su ne ƴaƴa mata masu shekaru 9 zuwa 14.
Menene illar ta ɓangaren mu da muka fi wannan shekarun ba mu dauka allurar ba?
Utar kansar mahaifa ita ce ta biyu mafi yawan cutar kansa a tsakanin mata. Matan da ke fama da cutar kansar mahaifa sau da yawa ba za su iya sake yin ciki ba saboda cutar tana shafar mahaifar su kuma sau da yawa jinyar ta haɗa da cire mahaifar ta hanyan tiyata.
Gabaɗaya, rigakafin HPV na maza da mata ne har zuwa shekaru 45. Amma a Najeriya, allurar
rigakafin a cibiyoyin kiwon lafiya na matakin farko mu samman na ƴaƴa mata masu shekaru 9-
14 ne. Wannan na iya canzawa daga baya ya haɗa da sauran rukunin shekaru a Najeriya. Duk
da gaka, idan kun girma ko ba ku da tabbacin ko kun cancanta, zaku iya tambayar likita a wani
asibiti mai zaman kansa game da samun allurar rigakafin.
Mata masu shayarwa za su iya samun rigakafin HPV lafiya lau. Ba ya cutar da jariri ko sa allurar
ta yi aiki kasa da yadda ake bukata. Yana da kyau a ci gaba da shayarwa bayan an yi allurar
Rigakafi.
Idan kuna zargin kuna da cutar ta HPV, yana da mahimmanci ku ziyarci asibiti kuma ku tuntubi likita. Likita zai tattauna alamomin cutar ku, ya ba da shawarar gwaje-gwaje masu dacewa, kuma ya ba da magani mafi dacewa dangane da sakamakon.
Ba a ba da shawarar baiwa rigakafin HPV ga mata masu juna biyu ba. Duk da haka, yana da kyau da lafiya ga mata masu shayarwa.
Iya, mutum mai hawan jini mai yawa zai iya karɓar rigakafin HPV. Duk da haka, yana da muhimmanci a tabbatar cewa hawan jinin nasa yana cikin hayyacin sa. Ya kamata ya ga likitansa kuma ya tabbatar cewa yana amfani da magungunan da suka dace kafin ya karɓi rigakafin.
Eh, wanda aka yi wa tiyatar cire nono zai iya karɓar allurar rigakafin HPV lafiya, domin tana karewa daga cutar kansa da cutar human papillomavirus (HPV) ke haifarwa, kuma ba ta dogara da lafiyar nono. Sai dai idan akwai wasu matsalolin kiwon lafiya na musamman, wannan allurar tana da aminci kuma ana ba da shawarar a yi ta. Idan kana
Ya ya batun ‘yan mata da suka haura shekaru 14?A halin yanzu, Hukumar Kula da Lafiyar Farko ta Ƙasa (NPHCDA) tana ba da shawarar a ba wa ‘yan mata masu shekaru 9 zuwa 14 allurar rigakafin HPV kyauta a cibiyoyin kiwon lafiyar farko. Duk da haka, waɗanda suka wuce wannan rukunin shekarun, ya kamata su tuntuɓi asibitocin masu zaman kansu don samun bayani.
Yarki na iya karɓar rigakafin HPV da zarar ta cika shekaru 9. Wannan yana nufin za ta iya samun allurar rigakafin kowanne lokaci daga Maris 2025 zuwa Fabrairu 2026. Ina mata fatan murnar ranar haihuwa a gaba. 🎂 🎉 🎁